Paul Young1, Mark Bailey2, Rinaldo Bellomo3, Stephen Bernard4, Bridget Dicker5, Ross Freebairn6, Seton Henderson7, Diane Mackle8, Colin McArthur9, Shay McGuinness9, Tony Smith10, Andrew Swain11, Mark Weatherall12, Richard Beasley8. 1. Medical Research Institute of New Zealand, PO Box 7902, Wellington, New Zealand; Wellington Hospital, Capital and Coast District Health Board, Private Bag 7902, Wellington, New Zealand. Electronic address: paul.young@ccdhb.org.nz. 2. Wellington Free Ambulance, PO Box 601, Wellington, New Zealand. 3. Intensive Care Unit, Austin Hospital, PO Box 5555, Heidelberg, 3084 Victoria, Australia; Australian and New Zealand Intensive Care Research Centre, The Alfred Centre, Level 6 (Lobby B), 99 Commercial Road, Melbourne, 3004 Victoria, Australia. 4. Alfred Hospital, 55 Commercial Road, Melbourne, 3004 Victoria, Australia. 5. St John Ambulance, 2 Harrison Road, Private Bag 14902, Panmure, Auckland, New Zealand. 6. Medical Research Institute of New Zealand, PO Box 7902, Wellington, New Zealand; Hawke's Bay Hospital, Omahu Road, Private Bag 9014, Hastings, New Zealand; Chinese University of Hong Kong, Sha Tin, Hong Kong, China. 7. Medical Research Institute of New Zealand, PO Box 7902, Wellington, New Zealand; Christchurch Hospital, 2 Riccarton Avenue, Christchurch, New Zealand. 8. Medical Research Institute of New Zealand, PO Box 7902, Wellington, New Zealand; Wellington Hospital, Capital and Coast District Health Board, Private Bag 7902, Wellington, New Zealand. 9. Medical Research Institute of New Zealand, PO Box 7902, Wellington, New Zealand; Australian and New Zealand Intensive Care Research Centre, The Alfred Centre, Level 6 (Lobby B), 99 Commercial Road, Melbourne, 3004 Victoria, Australia; Auckland City Hospital, 2 Park Road, Grafton, Auckland, New Zealand. 10. St John Ambulance, 2 Harrison Road, Private Bag 14902, Panmure, Auckland, New Zealand; Auckland City Hospital, 2 Park Road, Grafton, Auckland, New Zealand. 11. Wellington Hospital, Capital and Coast District Health Board, Private Bag 7902, Wellington, New Zealand; Wellington Free Ambulance, PO Box 601, Wellington, New Zealand. 12. Medical Research Institute of New Zealand, PO Box 7902, Wellington, New Zealand; Wellington Hospital, Capital and Coast District Health Board, Private Bag 7902, Wellington, New Zealand; University of Otago, School of Medicine, PO Box 7343, Wellington South, Wellington, New Zealand.
Abstract
AIMS: To investigate the feasibility of delivering titrated oxygen therapy to adults with return of spontaneous circulation (ROSC) following out-of-hospital cardiac arrest (OHCA) caused by ventricular fibrillation (VF) or ventricular tachycardia (VT). METHODS: We used a multicentre, randomised, single blind, parallel groups design to compare titrated and standard oxygen therapy in adults resuscitated from VF/VT OHCA. The intervention commenced in the community following ROSC and was maintained in the emergency department and the Intensive Care Unit. The primary end point was the median oxygen saturation by pulse oximetry (SpO2) in the pre-hospital period. RESULTS:159 OHCA patients were screened and 18 were randomised. 17 participants were analysed: nine in the standard care group and eight in the titrated oxygen group. In the pre-hospital period, SpO2 measurements were lower in the titrated oxygen therapy group than the standard care group (difference in medians 11.3%; 95% CI 1.0-20.5%). Low measured oxygen saturation (SpO2<88%) occurred in 7/8 of patients in the titrated oxygen group and 3/9 of patients in the standard care group (P=0.05). Following hospital admission, good separation of oxygen exposure between the groups was achieved without a significant increase in hypoxia events. The trial was terminated because accumulated data led the Data Safety Monitoring Board and Management Committee to conclude that safe delivery of titrated oxygen therapy in the pre-hospital period was not feasible. CONCLUSIONS: Titration of oxygen in the pre-hospital period following OHCA was not feasible; it may be feasible to titrate oxygen safely after arrival in hospital.
RCT Entities:
AIMS: To investigate the feasibility of delivering titrated oxygen therapy to adults with return of spontaneous circulation (ROSC) following out-of-hospital cardiac arrest (OHCA) caused by ventricular fibrillation (VF) or ventricular tachycardia (VT). METHODS: We used a multicentre, randomised, single blind, parallel groups design to compare titrated and standard oxygen therapy in adults resuscitated from VF/VT OHCA. The intervention commenced in the community following ROSC and was maintained in the emergency department and the Intensive Care Unit. The primary end point was the median oxygen saturation by pulse oximetry (SpO2) in the pre-hospital period. RESULTS: 159 OHCA patients were screened and 18 were randomised. 17 participants were analysed: nine in the standard care group and eight in the titrated oxygen group. In the pre-hospital period, SpO2 measurements were lower in the titrated oxygen therapy group than the standard care group (difference in medians 11.3%; 95% CI 1.0-20.5%). Low measured oxygen saturation (SpO2<88%) occurred in 7/8 of patients in the titrated oxygen group and 3/9 of patients in the standard care group (P=0.05). Following hospital admission, good separation of oxygen exposure between the groups was achieved without a significant increase in hypoxia events. The trial was terminated because accumulated data led the Data Safety Monitoring Board and Management Committee to conclude that safe delivery of titrated oxygen therapy in the pre-hospital period was not feasible. CONCLUSIONS: Titration of oxygen in the pre-hospital period following OHCA was not feasible; it may be feasible to titrate oxygen safely after arrival in hospital.
Authors: Jerry P Nolan; Robert A Berg; Stephen Bernard; Bentley J Bobrow; Clifton W Callaway; Tobias Cronberg; Rudolph W Koster; Peter J Kudenchuk; Graham Nichol; Gavin D Perkins; Tom D Rea; Claudio Sandroni; Jasmeet Soar; Kjetil Sunde; Alain Cariou Journal: Intensive Care Med Date: 2017-03-11 Impact factor: 17.440
Authors: Brian W Roberts; J Hope Kilgannon; Benton R Hunter; Michael A Puskarich; Lisa Pierce; Michael Donnino; Marion Leary; Jeffrey A Kline; Alan E Jones; Nathan I Shapiro; Benjamin S Abella; Stephen Trzeciak Journal: Circulation Date: 2018-02-01 Impact factor: 29.690
Authors: Henry E Wang; David K Prince; Ian R Drennan; Brian Grunau; David J Carlbom; Nicholas Johnson; Matthew Hansen; Jonathan Elmer; Jim Christenson; Peter Kudenchuk; Tom Aufderheide; Myron Weisfeldt; Ahamed Idris; Stephen Trzeciak; Michael Kurz; Jon C Rittenberger; Denise Griffiths; Jamie Jasti; Susanne May Journal: Resuscitation Date: 2017-09-21 Impact factor: 5.262
Authors: Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar Journal: Intensive Care Med Date: 2021-03-25 Impact factor: 17.440
Authors: Jasmeet Soar; Katherine M Berg; Lars W Andersen; Bernd W Böttiger; Sofia Cacciola; Clifton W Callaway; Keith Couper; Tobias Cronberg; Sonia D'Arrigo; Charles D Deakin; Michael W Donnino; Ian R Drennan; Asger Granfeldt; Cornelia W E Hoedemaekers; Mathias J Holmberg; Cindy H Hsu; Marlijn Kamps; Szymon Musiol; Kevin J Nation; Robert W Neumar; Tonia Nicholson; Brian J O'Neil; Quentin Otto; Edison Ferreira de Paiva; Michael J A Parr; Joshua C Reynolds; Claudio Sandroni; Barnaby R Scholefield; Markus B Skrifvars; Tzong-Luen Wang; Wolfgang A Wetsch; Joyce Yeung; Peter T Morley; Laurie J Morrison; Michelle Welsford; Mary Fran Hazinski; Jerry P Nolan Journal: Resuscitation Date: 2020-10-21 Impact factor: 5.262